Prognostic factors and staging systems in childhood hepatoblastoma

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 593-599

  Von Schweinitz, Dietrich ^a   Hecker, Hartmut ^a   Schmidt Von Arndt, Gabriele ^a   Harms, Dieter ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IFOSFAMIDE;

ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; CHILDHOOD CANCER; HEPATOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER TUMOR; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS;

EID: 0031456840     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P     Document Type: Article

References (22)

1. ALBRECHT, S., VON SCHWEINITZ, D., WAHA. A., KRAUS, J.A., VON DEIMLING, A. and PIETSCH, T., Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res., 54, 5041-5044 (1994).
2. CIAMPI, A., HOGG, S.H., MCKINNEY, S. and THIFFAULT, J., RECPAM: a computer program for recursive partitioning and amalgamation for censored survival data and other situations frequently occurring in biostatistics. Comput. Meth. Progr. Biomed., 26, 239-256 (1988).
3. CONRAN, R.M., HITCHKOCK, C.L., WACLAWIW, M.A., STOCKER, J.T. and ISHAK, K.G., Hepatoblastoma: the prognostic significance of histologic type. Pediatr. Pathol., 12, 167-183 (1992).
4. Cox, D.R., Regression models and life tables. J. roy. statist. Soc., 34, 187-220 (1972).
5. DOUGLASS, E.C., REYNOLDS, M., FINEGOLD, M., CANTOR, A.B. and GLICKSMAN, A., Cisplatin, vincristine and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J. clin. Oncol., 11, 96-99 (1993).
6. HAAS, J.E., MUCZINSKY, K.A., KRAILO, M., ABLIN, A., LAND, V., VIETTI, T.J. and HAMMOND, G.D., Histopathology and prognosis in childhood hepato-blastoma and hepatocarcinoma. Cancer, 64, 1082-1095 (1989).
7. HECKER, H. and WÜBBELT, P., Clustering by response: CBR. Comput. Statist. Data Anal., 24, 193-215 (1997).
8. HERMANEK, P., HENSON, D.E., HUTTER, R.V.P. and SOBIN, L.H., UICC: TNM Supplement 1993. In: UICC: TNM supplement. A commentary for uniform use, pp. 97-99, Springer, Berlin (1993).
9. HERMANEK, P. and SOBIN, J.H., UICC: TNM classification of malignant tumours, 4th ed., pp. 59-61, Springer, Berlin (1992).
10. KALBFLEISCH, J.D. and PRENTICE, R.L., The statistical analysis of failure time data. J. Wiley, New York (1980).7
11. KAPLAN, E.L. and MEIER, P., Non-parametric estimation from incomplete observations. J. Amer. statist. Ass., 53, 457-481 (1958).
12. MACKINLEY, G.A. and PRITCHARD, J., A common language for childhood liver tumours. Pediatr. Surg. Int., 7, 325-326 (1992).
13. MANN, J.R., KASTHURI, N., RAAFAT, F., PINCOTT, J.R., PARKES, S.E., MUIR, K.R., INGRAM, L.C. and CAMERON, A.H., Malignant hepatic tumours in children: incidence, clinical features and aetiology. Pediatr. perinat. Epidemiol., 4, 276-289 (1990).
14. MORITA, K. and 14 OTHERS, The proposed Japanese TNM classification of primary liver carcinoma in infants and children. Jap. J. clin. Oncol., 13, 361-370 (1983).
15. ORTEGA, J.A., KRAILO, M.D., HAAS, J.E., KING, D.R., ABLIN, A.R., QUINN, J.J., FEUSNER, J., CAMPBELL, J.R., LLOYD, D.A., CHERLOW, J. and HAMMOND, G.D., Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous-infusion doxorubicin chemotherapy: a report from the Children's Cancer Study Group. J. clin. Oncol., 9, 2167-2176 (1991).
16. PLASCHKES, J., PERILONGO, G., SHAFFORD, E., BROCK, P., BROWN, J., DICKS-MIREAU, C., HABRAND, J.-L., KEELING, J., PHILLIPS, A., PRITCHARD, J. and Vos, A., SIOP trial report-overall preliminary results of SIOPEL-1 for treatment of hepatoblastoma (HB) with pre-operative chemotherapy- continuous-infusion cisplatin and doxorubicin (PLADO). (Abstract) Med. pediatr. Oncol., 23, 170 (1994).
17. SCHMIDT, D., WISCHMEYER, P., LEUSCHNER, I., SPRENGER, E., LANGENAU, E., VON SCHWEINITZ, D. and HARMS, D., DNA analysis in hepatoblastoma by How and image cytometry. Cancer, 72, 2914-2919 (1993).
18. SHAFFORD, E.A. and PRITCHARD, J., Hepatoblastoma-a bit of a success story? Europ. J. Cancer, 30A, 1050-1051 (1994).
19. VON SCHWEINITZ, D., BÜRGER, D., BODE, U., WEINEL, P., ERTTMANN, R., HECKER, H. and MILDENBERGER, H., Results of the study HB-89 in the treatment of malignant epithelial liver tumors of childhood and concept for a new protocol HB-94. Klin. Pädiatr., 206, 282-288 (1994a).
20. VON SCHWEINITZ, D., HECKER, H., HARMS, D., BODE, U., WEINEL, P., BÜRGER, D., ERTTMANN, R. and MILDENBERGER, H., Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma. A report from the German Cooperative Pediatric-Liver-Tumor Study HB-89. J. pediatr. Surg., 30, 845-852 (1995).
21. VON SCHWEINITZ, D., WISCHMEYER, P., LEUSCHNER, I., SCHMIDT, D., WITTEKIND, C., HARMS, D. and MILDENBERGER, H., Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Europ. J. Cancer, 30A, 1052-1058 (1994b).
22. WEINBERG, A.G. and FINEGOLD, M.J., Primary hepatic tumors of childhood. Hum. Pathol., 14, 512-537 (1983).